Home Biomarkers WIDAL TEST (SLIDE METHOD)

WIDAL TEST (SLIDE METHOD)

Bacterial infections Biomarker

Sample Needed

Collection Type: Blood

Body System

Related System: Bacterial infections

Overview

The Widal test (slide method) is a rapid serologic screening test that detects agglutinating antibodies in a patient’s serum against Salmonella enterica serovar Typhi and Paratyphi antigens—primarily O (somatic) and H (flagellar) antigens. It measures whether the patient has circulating anti-Salmonella antibodies that cause visible clumping (agglutination) when mixed with antigen on a slide. It is used when enteric fever (typhoid or paratyphoid) is suspected—typical symptoms include prolonged fever, abdominal pain, headache, malaise, and sometimes diarrhea or constipation. Results can vary with age, prior vaccination or past infection, and by geography: people in endemic areas often have higher baseline titres; children may show lower or delayed antibody responses. The slide method is qualitative/semquantitative and less specific than quantitative tube titres or blood culture.

People also test for

Test Preparation

No special preparation is required

Why Do I Need This Test

Profile: Bacterial infections - Symptoms indicating testing: prolonged fever, abdominal pain, headache, GI symptoms, history of travel to endemic area - Diagnoses/monitoring: suspected typhoid or paratyphoid fever (screening) - Reasons for abnormal results: recent or past Salmonella infection, recent vaccination, cross‑reacting antibodies from other infections, endemic background immunity - Biological meaning: elevated agglutinating antibodies suggest exposure or immune response to Salmonella antigens - Behaviors/lifestyle: recent travel, poor sanitation, contaminated food/water increase likelihood - Family history: household exposure to confirmed enteric fever or carriers indicates need for testing

Run our symptom checker to see if this test is right for you

Symptom Checker

Understanding Test Results

A negative or titre below 1:80 generally indicates no detectable agglutinating antibodies to Salmonella Typhi/Paratyphi and makes acute enteric fever less likely.
Low titres (around 1:80) can represent past exposure, vaccination, or background immunity in endemic areas.
Intermediate titres (approximately 1:80–1:160) are equivocal and must be interpreted with clinical findings and local baseline titres; they may reflect early infection or non‑specific cross‑reactivity.
High titres (commonly ≥1:160 to ≥1:320, depending on local cutoffs) on slide testing suggest recent or active infection but are not definitive; confirmation requires quantitative tube titres, demonstration of a fourfold rise in paired sera (acute and convalescent), and/or blood culture (gold standard).
False positives occur with prior vaccination, other infections, or cross‑reacting antibodies; false negatives can occur early in illness before antibody development.
Clinical correlation and confirmatory testing are essential.

Normal Range

Negative <1:80 (titre, reciprocal dilution)

FAQs

Q: What is the slide method for Widal test?

A: The slide method for the Widal test is a rapid agglutination screening where a drop of patient serum is mixed on a glass slide with standardized Salmonella O and H antigen suspensions. After gentle mixing and rotation for about 1–2 minutes at room temperature, visible clumping indicates a positive reaction. It’s a qualitative, preliminary test; positive results are confirmed by quantitative tube agglutination and titres.

Q: How to read Widal test slide method report?

A: Read the slide Widal by noting agglutination for O and H antigens (Salmonella typhi and paratyphi). Results are reported qualitatively (negative, 1+ to 4+ or agglutination). Positive O titres suggest recent infection; predominant H may reflect past exposure or carrier state. Confirm with quantitative tube titres and paired acute–convalescent sera; interpret with the clinical picture due to cross-reactions.

Q: What if the Widal slide test is positive?

A: If the Widal slide test is positive, it suggests possible Salmonella typhi/paratyphi exposure but is not definitive. Confirm with blood culture and quantitative titres, repeat testing if needed, and correlate with symptoms and fever duration. False positives can occur from prior vaccination, past infection, or cross‑reacting bacteria. Management—antibiotics or further workup—should be guided by a clinician based on confirmatory tests and clinical assessment.

Q: Which is better, Widal slide or tube?

A: Tube (quantitative) Widal is better than the slide (qualitative) test because it measures antibody titers, improving specificity and allowing serial monitoring with fewer false positives. Both methods have limitations—cross‑reactivity, prior vaccination or antibiotics can alter results—so blood culture remains the diagnostic gold standard and Widal findings should be interpreted with clinical context and serial titers.

Q: What is the slide method of blood test?

A: The slide method (peripheral blood smear) places a drop of blood on a glass slide, spreads it thin, air-dries and stains (e.g., Wright or Giemsa). A microscope exam evaluates red and white cell morphology, platelets and parasites. It helps diagnose anemia, infections, blood disorders and malaria. The test is rapid and inexpensive but operator-dependent and not a precise quantitative measure.

Q: What is the principle of Widal test Slideshare?

A: The Widal test is a serological agglutination assay that detects patient antibodies against Salmonella enterica serovar Typhi and Paratyphi O (somatic) and H (flagellar) antigens. Patient serum is mixed with standardized antigen suspensions; visible agglutination indicates presence and titre of specific antibodies. A significant rise in paired sera titres or a high single titre supports recent or current typhoid infection, though cross-reactions can occur.